Back to MW MARSHALL WACE, LLP

CRBPCRBP
7 quarters

Position history for MWMARSHALL WACE, LLP's holdings in CORBUS PHARMACEUTICALS HLDGS

MARSHALL WACE, LLP holds 79,331 shares of CRBP (CORBUS PHARMACEUTICALS HLDGS), worth $744,125 as of 2026-Q2. The position was decreased (-45.9% shares). CRBP represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$744,125

Current Shares

79,331

Total Value Change

+$350,649

Total Shares Change

+60,258

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
79,331
-45.9%
$744,1250.0%$9.38
0
2026-Q1
Increased
146,596
+89.0%
$1.4M0.0%$8.21
40
2025-Q4
Decreased
77,546
-24.4%
$631,2260.0%$8.01
0
2025-Q3
Increased
102,509
+415.9%
$1.3M0.0%$12.26
41
2025-Q2
New
19,871
-
$137,1100.0%$7.40
31
2024-Q4
Exited
0
-100.0%
$00.0%$12.08
0
2024-Q3
New
19,073
-
$393,4760.0%$20.92
33

Other major holders of CRBP: BlackRock Finance, Inc., Point72 Asset Management, L.P., STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used